A Comparison of Manufacturing Processes for AIR OPTIX® COLORS Contact Lens
AIR OPTIX® COLORS: Automated vs Semi-automated Manufacturing Processes
2 other identifiers
interventional
49
0 countries
N/A
Brief Summary
The purpose of this feasibility study was to compare AIR OPTIX® COLORS contact lenses manufactured using an automated process to AIR OPTIX® COLORS contact lenses manufactured using a semi-automatic process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2012
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 5, 2012
CompletedFirst Posted
Study publicly available on registry
June 8, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedMay 5, 2017
February 1, 2014
2 months
June 5, 2012
May 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall satisfaction
The participant was asked, "Please rate your overall satisfaction based on your experience with the study lenses over the last 2 weeks. When considering your rating, please take into account comfort, vision, and handling, but disregard the appearance of the lenses." Overall satisfaction was rated on a scale of 1-10, with 1=Not at all satisfied, and 10=Completely satisfied.
Week 2
Secondary Outcomes (4)
Overall lens fit
Dispense (Day 0)
Overall lens fit
Week 2
Contact Lens Corrected Visual Acuity (CLCVA)
Dispense (Day 0)
Corrected distance monocular visual measurement in normal illumination reported as Contact Lens Corrected Visual Acuity (CLCVA)
Week 2
Study Arms (2)
AIR OPTIX® COLORS Auto, then AIR OPTIX® COLORS Semi-auto
OTHERLotrafilcon B contact lens with color, automated, worn first, with Lotrafilcon B contact lens with color, semi-automated, worn second. Each product worn on a daily wear basis approximately 8 hours a day, 5 days a week, for 2 weeks.
AIR OPTIX® COLORS Semi-auto, then AIR OPTIX® COLORS Auto
OTHERLotrafilcon B contact lens with color, semi-automated, worn first, with Lotrafilcon B contact lens with color, automated, worn second. Each product worn on a daily wear basis approximately 8 hours a day, 5 days a week, for 2 weeks.
Interventions
Silicone hydrogel contact lens with color manufactured via an automated process
Silicone hydrogel contact lens with color manufactured via a semi-automated process
Eligibility Criteria
You may qualify if:
- Able and willing to sign a written Informed Consent form.
- Cylinder ≤ -0.75 diopter (D).
- Able to achieve visual acuity (VA) of at least 20/30 Snellen in each eye at distance with contact lenses (CLCVA) and best corrected visual acuity (BCVA) ≥ 20/25.
- Have spectacles that provide acceptable vision and be willing to wear them if unable to wear the study lenses.
- Successful daily wear of single-vision spherical soft contact lenses in both eyes during the past 3 months for a minimum of 8 hours/day, 5 days/week.
You may not qualify if:
- Eye injury or surgery within twelve weeks immediately prior to enrollment in this trial.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in an ophthalmic clinical trial.
- Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of accessory solutions, as determined by the investigator.
- Pathologically dry eye.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CIBA VISIONlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sharon Holden Thomas, O.D.
Alcon Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2012
First Posted
June 8, 2012
Study Start
June 1, 2012
Primary Completion
August 1, 2012
Study Completion
August 1, 2012
Last Updated
May 5, 2017
Record last verified: 2014-02